Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23


Targeting of free fatty acid receptor 1 in EOC: A novel strategy to restrict the adipocyte-EOC dependence.

Munkarah A, Mert I, Chhina J, Hamid S, Poisson L, Hensley-Alford S, Giri S, Rattan R.

Gynecol Oncol. 2016 Apr;141(1):72-9. doi: 10.1016/j.ygyno.2016.02.026.


Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy.

Peng D, Kryczek I, Nagarsheth N, Zhao L, Wei S, Wang W, Sun Y, Zhao E, Vatan L, Szeliga W, Kotarski J, Tarkowski R, Dou Y, Cho K, Hensley-Alford S, Munkarah A, Liu R, Zou W.

Nature. 2015 Nov 12;527(7577):249-53. doi: 10.1038/nature15520. Epub 2015 Oct 26.


A metabolomic approach to identifying platinum resistance in ovarian cancer.

Poisson LM, Munkarah A, Madi H, Datta I, Hensley-Alford S, Tebbe C, Buekers T, Giri S, Rattan R.

J Ovarian Res. 2015 Mar 26;8:13. doi: 10.1186/s13048-015-0140-8.


A new approach to assessing affect and the emotional implications of personal genomic testing for common disease risk.

O'Neill SC, Tercyak KP, Baytop C, Hensley Alford S, McBride CM.

Public Health Genomics. 2015;18(2):104-12. doi: 10.1159/000370101. Epub 2015 Jan 21.


The influence of comorbid conditions on racial disparities in endometrial cancer survival.

Ruterbusch JJ, Ali-Fehmi R, Olson SH, Sealy-Jefferson S, Rybicki BA, Hensley-Alford S, Elshaikh MA, Gaba AR, Schultz D, Munkarah AR, Cote ML.

Am J Obstet Gynecol. 2014 Dec;211(6):627.e1-9. doi: 10.1016/j.ajog.2014.06.036. Epub 2014 Jun 19.


Characteristics associated with genetic counseling referral and BRCA1/2 testing among women in a large integrated health system.

Bellcross CA, Peipins LA, McCarty FA, Rodriguez JL, Hawkins NA, Hensley Alford S, Leadbetter S.

Genet Med. 2015 Jan;17(1):43-50. doi: 10.1038/gim.2014.68. Epub 2014 Jun 19.


The impact of multiplex genetic testing on disease risk perceptions.

Shiloh S, deHeer HD, Peleg S, Hensley Alford S, Skapinsky K, Roberts JS, Hadley DW.

Clin Genet. 2015 Feb;87(2):117-23. doi: 10.1111/cge.12403. Epub 2014 May 20.


On averages and peaks: how do people integrate attitudes about multiple diseases to reach a decision about multiplex genetic testing?

Shiloh S, Wade CH, Roberts JS, Hensley Alford S, Biesecker BB.

Med Decis Making. 2013 Jan;33(1):71-7. doi: 10.1177/0272989X12464432. Epub 2012 Nov 5.


Judging risk for multiple diseases: the role of disease worry.

Senay I, Hensley-Alford S, Kaphingst KA.

J Health Psychol. 2013 Apr;18(4):554-60. doi: 10.1177/1359105312437263. Epub 2012 Jul 27.


Preferences among diseases on a genetic susceptibility test for common health conditions: an ancillary study of the multiplex initiative.

Wade CH, Shiloh S, Roberts JS, Hensley Alford S, Marteau TM, Biesecker BB.

Public Health Genomics. 2012;15(6):322-6. doi: 10.1159/000338114. Epub 2012 Jun 8. No abstract available.


Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.

Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED, Fouad MN, Isaacs C, Johnson CC, Reding DJ, O'Brien B, Carrick DM, Wright P, Riley TL, Purdue MP, Izmirlian G, Kramer BS, Miller AB, Gohagan JK, Prorok PC, Berg CD; PLCO Project Team.

N Engl J Med. 2012 Jun 21;366(25):2345-57. doi: 10.1056/NEJMoa1114635. Epub 2012 May 21.


Skin cancer concerns and genetic risk information-seeking in primary care.

Hay J, Kaphingst KA, Baser R, Li Y, Hensley-Alford S, McBride CM.

Public Health Genomics. 2012;15(2):57-72. doi: 10.1159/000330403. Epub 2011 Sep 13.


Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.

Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, Reding DJ, Greenlee RT, Yokochi LA, Kessel B, Crawford ED, Church TR, Andriole GL, Weissfeld JL, Fouad MN, Chia D, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hartge P, Pinsky PF, Zhu CS, Izmirlian G, Kramer BS, Miller AB, Xu JL, Prorok PC, Gohagan JK, Berg CD; PLCO Project Team.

JAMA. 2011 Jun 8;305(22):2295-303. doi: 10.1001/jama.2011.766.


Parents' attitudes toward pediatric genetic testing for common disease risk.

Tercyak KP, Hensley Alford S, Emmons KM, Lipkus IM, Wilfond BS, McBride CM.

Pediatrics. 2011 May;127(5):e1288-95. doi: 10.1542/peds.2010-0938. Epub 2011 Apr 18.


The role of lymph node metastasis in the systemic dissemination of breast cancer.

Nathanson SD, Kwon D, Kapke A, Hensley Alford S, Chitale D.

Indian J Surg Oncol. 2010 Dec;1(4):313-22. doi: 10.1007/s13193-011-0063-9. Epub 2011 Mar 29.


Participation in genetic testing research varies by social group.

Hensley Alford S, McBride CM, Reid RJ, Larson EB, Baxevanis AD, Brody LC.

Public Health Genomics. 2011;14(2):85-93. doi: 10.1159/000294277. Epub 2010 Mar 18.


Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid.

Fagerlin A, Zikmund-Fisher BJ, Nair V, Derry HA, McClure JB, Greene S, Stark A, Hensley Alford S, Lantz P, Hayes DF, Wiese C, Claud Zweig S, Pitsch R, Jankovic A, Ubel PA.

Breast Cancer Res Treat. 2010 Feb;119(3):613-20. doi: 10.1007/s10549-009-0618-4.


Pregnancy associated smoking behavior and six year postpartum recall.

Hensley Alford SM, Lappin RE, Peterson L, Johnson CC.

Matern Child Health J. 2009 Nov;13(6):865-72. doi: 10.1007/s10995-008-0417-2. Epub 2008 Sep 26.


Breast cancer characteristics at diagnosis and survival among Arab-American women compared to European- and African-American women.

Hensley Alford S, Schwartz K, Soliman A, Johnson CC, Gruber SB, Merajver SD.

Breast Cancer Res Treat. 2009 Mar;114(2):339-46. doi: 10.1007/s10549-008-9999-z. Epub 2008 Apr 15.


Racial and age differences in colon examination surveillance following a diagnosis of colorectal cancer.

Rolnick S, Hensley Alford S, Kucera GP, Fortman K, Ulcickas Yood M, Jankowski M, Johnson CC.

J Natl Cancer Inst Monogr. 2005;(35):96-101.


Supplemental Content

Loading ...
Support Center